Detalhe da pesquisa
1.
Correspondence in reference to the previously published manuscript: Reduction of cycles of bendamustine plus rituximab therapy in the cases with good response for indolent B-cell lymphomas.
Hematol Oncol
; 41(3): 571-573, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-35319789
2.
Safety and effectiveness of ruxolitinib in the real-world management of polycythemia vera patients: a collaborative retrospective study by pH-negative MPN latial group.
Ann Hematol
; 101(6): 1275-1282, 2022 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-35318505
3.
Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the "Ph1-negative Myeloproliferative Neoplasms Latium Group".
Eur J Haematol
; 105(3): 335-343, 2020 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-32441419
4.
Preliminary results of a counselling programme for fertility preservation in female cancer patients: The experience of the GEMME DORMIENTI network.
Eur J Cancer Care (Engl)
; 29(1): e13174, 2020 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-31571303
5.
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors.
Hematol Oncol
; 37(3): 291-295, 2019 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-31050810
6.
Cyclophosphamide's addition in relapsed/refractory multiple myeloma patients with biochemical progression during lenalidomide-dexamethasone treatment.
Eur J Haematol
; 2018 May 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29719938
7.
Life for patients with myelofibrosis: the physical, emotional and financial impact, collected using narrative medicine-Results from the Italian 'Back to Life' project.
Qual Life Res
; 27(6): 1545-1554, 2018 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29520559
8.
Ruxolitinib in clinical practice for primary and secondary myelofibrosis: an analysis of safety and efficacy of Gruppo Laziale of Ph-negative MPN.
Ann Hematol
; 96(3): 387-391, 2017 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-27889820
9.
ITACA: A new validated international erythropoietic stimulating agent-response score that further refines the predictive power of previous scoring systems.
Am J Hematol
; 92(10): 1037-1046, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28675513
10.
Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase.
Eur J Haematol
; 96(6): 643-9, 2016 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-26277477
11.
Spleen enlargement is a risk factor for thrombosis in essential thrombocythemia: Evaluation on 1,297 patients.
Am J Hematol
; 91(3): 318-21, 2016 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-26748894
12.
Arterial and venous thrombosis in patients with monoclonal gammopathy of undetermined significance: incidence and risk factors in a cohort of 1491 patients.
Br J Haematol
; 160(5): 673-9, 2013 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-23240810
13.
Risk factors for impaired gonadal function in female Hodgkin lymphoma survivors: final analysis of a retrospective multicenter joint study from Italian and Brazilian Institutions.
Hematol Oncol
; 31(2): 72-8, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23027689
14.
Immunotactoid glomerulopathy and chronic lymphocytic leukemia: The need for a multidisciplinary approach.
EJHaem
; 4(1): 266-268, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36819169
15.
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study.
Cancers (Basel)
; 15(14)2023 Jul 21.
Artigo
Inglês
| MEDLINE | ID: mdl-37509367
16.
Symptomatic mucocutaneous toxicity of hydroxyurea in Philadelphia chromosome-negative myeloproliferative neoplasms: the Mister Hyde face of a safe drug.
Cancer
; 118(2): 404-9, 2012 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-21692060
17.
Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group.
EJHaem
; 3(1): 121-128, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-35846211
18.
Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma.
Clin Gastroenterol Hepatol
; 8(2): 105-10, 2010 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-19631287
19.
Primary low-grade and high-grade gastric MALT-lymphoma presentation.
J Clin Gastroenterol
; 44(5): 340-4, 2010.
Artigo
Inglês
| MEDLINE | ID: mdl-19745757
20.
Front-Line Therapy for Elderly Chronic Lymphocytic Leukemia Patients: Bendamustine Plus Rituximab or Chlorambucil Plus Rituximab? Real-Life Retrospective Multicenter Study in the Lazio Region.
Front Oncol
; 10: 848, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-32587827